Outpatient Surgery Magazine

Manager's Guide to Surgery's Ambulatory Anesthesia - July 2015

Outpatient Surgery Magazine, providing current information on Surgical Services, Surgical Facility Administration, Outpatient Surgery News and Trends, OR Excellence and more.

Issue link: http://outpatientsurgery.uberflip.com/i/538156

Contents of this Issue

Navigation

Page 13 of 68

1 4 S U P P L E M E N T T O O U T P A T I E N T S U R G E R Y M A G A Z I N E J U LY 2 0 1 5 forced to admit that a clinical study that demonstrated that Exparel significantly reduced pain intensity compared to placebo for up to 24 hours also demonstrated that "there was minimal to no difference between Exparel and placebo treatments on mean pain intensity" between 24 and 72 hours after Exparel was adminis- tered. The FDA also said Pacira had subtly pro- moted the use of Exparel in surgical pro- cedures other than those for which the drug has been shown to be safe and effective. The agency "is con- cerned with Pacira's suggestions, made in an array of professionally- directed promotional materials … that Four numbers have been used to express how long Exparel works — or doesn't work. 96 Exparel's physician advocates often say that plasma levels of bupiva- caine can remain in your system for up to 96 hours, or 4 days, and that bupivacaine continues to be released from the liposome during that time. "Not to say that patients will have pain relief for that long, but plasma levels of bupivacaine can persist for up to 96 hours," says Peter Whang, MD, FACS, a Pacira consultant who's an associate professor in the department of orthope- dics and rehabilitation at the Yale University School of Medicine in New Haven, Conn. 72 The FDA last September objected to Pacira Pharmaceuticals' claims that Exparel provides pain control that lasts for up to 72 hours, about 10 times longer than standard bupivacaine. "Exparel is heavily dependent on how you infiltrate it," says a Pacira consultant who spoke on the condition of anonymity. "When you infiltrate straight bupivacaine, it spreads. When you inject Exparel, it only works where you place it." 48 A little more than a year ago, Dr. Whang was quoted as saying, "We can administer the bupivacaine immediately post-operatively and can expect pain relief for up to 72 hours." When Outpatient Surgery asked Dr. Whang last month how much pain relief you can reasonably expect from Exparel, he scaled back on his estimate. "You can count on 48 hours of relief," he says. 24 This is the maximum number of hours the FDA says the drug works. "Exparel demonstrates significant reduction in pain intensity scores when compared to placebo for up to 24 hours," reads Exparel's amended claim in resolution to a recent FDA warning letter. FDA reviewer Arthur Simone, MD, PhD, points out that "the duration of Exparel's analgesic effect appears to be no more than 24 hours and not longer than that of bupivacaine hydrochlo- ride" — Dan O'Connor SLIDING SCALE How Many Days?

Articles in this issue

Archives of this issue

view archives of Outpatient Surgery Magazine - Manager's Guide to Surgery's Ambulatory Anesthesia - July 2015